Industry & Business

Fusion Antibodies Doubling Workforce as it Targets Global Business

 Breaking News
  • Electric Ireland Awards €30 Million Customer Services Contract Electric Ireland has chosen Abtran, the leading Irish business process management company, as their continuing partner in the delivery of customer service solutions to its 1.2 million residential and business customers nationwide. The contract has an approximate value of €30 million over 3 years to 2022, with an option to extend for a further 4 years. Abtran’s [...]...
  • Bibby Financial Services Ireland Opens Cork Office To facilitate an increase in business in the Munster region, Bibby Financial Services Ireland (BFSI), a leading provider of financial support and funding solutions to Irish SMEs, has opened its new Cork office. The new office, located at Unit 10, South Bank, Crosse’s Green in Cork city centre will be led by recently-appointed Head of Sales [...]...
  • Esri Ireland Partners With Causeway Coast and Glens Borough Council to Boost Local Tourism Esri Ireland, the market leader in geographic information services, has announced that Causeway Coast and Glens Borough Council has used its digital mapping software to boost local tourism through a series of interactive online maps. The Council has seen significant tourism growth in the Causeway Coast and Glens region, with 1.1 million overnight visitors adding [...]...
  • Ireland Improves Performance in European Digitisation Index The Government has welcomed the news from the European Commission that Ireland has improved its performance in the 2019 EU Digital Economy and Society Index (DESI) compared to 2018. Our performance is ahead of the European average in four of the five indicators. Ireland improved its overall ranking by one place, moving from 8th to 7th place in [...]...
  • HEINEKEN Ireland Ahead on Sustainability Targets HEINEKEN Ireland has published its 2018 Sustainability Report which saw the brewer achieve a 58% reduction in CO2 production since 2008, far exceeding its own 20% target. This achievement underscores its 10 year commitment to be a sustainable and green brewer under its global sustainability strategy, Brewing a Better World. In 2018, as part of its [...]...

Fusion Antibodies Doubling Workforce as it Targets Global Business

Fusion Antibodies Doubling Workforce as it Targets Global Business
May 28
10:36 2018

Belfast-based Clinical Research firm, Fusion Antibodies has announced plans to create 28 new jobs. This recruitment drive, supported by Invest Northern Ireland, will help Fusion deliver its services to its growing international customer base.

The company’s antibody engineering technology assists in the development of novel biological molecules that are used as innovative drugs for human diseases including cancer, coeliac disease, chronic fungal infections and immunological indications.

Announcing the expansion, Paul Kerr, Managing Director of Fusion Antibodies, said: “Invest NI continues to provide excellent support as we look to expand the business rapidly and to capitalise on our position as a successful international CRO providing a range of antibody engineering services. The work to more than double the capacity of our laboratory and office space is expected to be completed by the end of the summer, ahead of our original schedule. The new employees will include technically skilled staff working to deliver our current services to biopharma companies.

“We are also recruiting scientists with specialised skills to work in our new product development team on the establishment of our antibody affinity maturation service and the creation of a mammalian antibody library. In addition, our growth strategy, focussed on reinvigorating and expanding our new business development and sales function, will benefit from further resource in this area.”

Invest NI has offered Fusion Antibodies £213,000 towards its job creation and marketing activities.

Grainne McVeigh, Invest NI’s Director of Life Sciences, said: “This expansion is an exciting milestone for Fusion Antibodies which is among a dynamic group of companies contributing to our growing Life and Health Sciences sector. Invest NI has been working alongside the business for many years and we are delighted to be helping Fusion Antibodies to scale up its workforce and target market opportunities with drug development and diagnostics companies across the globe.”

CAPTION:

Pictured (L-R): Grainne McVeigh, Director of Life Sciences, Invest Northern Ireland, and Paul Kerr, Managing Director of Fusion Antibodies.

About Author

admin

admin

Related Articles

New Subscriber

Subscribe Here



Advertisements





















National Manufacturing Conference & Exhibition 2018

NIBRT Springboard Success Stories



Upcoming Events

  • No upcoming events
AEC v1.0.4